Cyclin E serves as a potent prognostic indicator of breast cancer and plays a crucial role in determining tumor aggressiveness and predicting the recurrence of TNBC (Guerrero Llobet et al., 2020). This evidence concerns the gene CCNE1 and breast cancer.